Charles river laboratories international inc
Biotechnology:-Commercial-Physical-&-Biological-Resarch
CRL
251 Ballardvale Street
Wilmington , MA 01887
Wilmington , MA 01887
Executive/
Director
Links
Price
- Last Close
-
$ 201.79
$ +10.11 5.27 %
Dec 9, 2024
- 52-Week High/Low
- $273.43 - $164.53
- YTD
- -14.6%
- Trading Volume
- 22,876
- Market Cap Full
- $ 10.4B
- Shares Outstanding
-
51.3M
Oct 27, 2023
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Q1 | 24.6% | -5.5% | 18.1% | -2.5% | 28.3% | -5% | 16% | -23.2% | -7.3% | 14.7% |
Q2 | -11.3% | 8.6% | 12.5% | 8.9% | -2.1% | 4% | 27.6% | -26% | 4.2% | -2.7% |
Q3 | -9.7% | 1.1% | 6.8% | 20% | -8.2% | 8% | 11.6% | -8% | -6.8% | - |
Q4 | 26.6% | -8.6% | 0.5% | -15.3% | 15.5% | 10.5% | -8.7% | 10.7% | 22.2% | - |
J | F | M | A | M | J | J | A | S | O | N | D | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -8.5% | 17.5% | 6.7% | -3.4% | - | - | - | - | - | - | - | - |
2023 | 11.6% | -9.9% | -7.9% | -5.8% | 1.7% | 8.7% | -0.4% | -1.3% | -5.2% | -14.1% | 17% | 19.9% |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
20% | 26% | -5% | 44% | 3% | 34% | 64% | 51% | -42% | 8% | -15% |
Earnings
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|
Q1 | 0.79 | 0.98 | 1.29 | 1.08 | 1.11 | 1.02 | 1.2 | 1.81 | 2.01 |
Q2 | 0.96 | 1.20 | 1.29 | 1.1 | 0.88 | 1.34 | 1.72 | 2.13 | 1.89 |
Q3 | 1.03 | 1.18 | 1.30 | 1.22 | 1.46 | 2.03 | 2.01 | 1.88 | 1.69 |
Q4 | 1 | 1.21 | 1.40 | 1.22 | 1.62 | 2.81 | 2.67 | 3.66 | - |
A | 3.8 | 4.6 | 5.3 | 4.6 | 5.1 | 7.2 | 7.6 | 9.5 | 5.59 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Mar | - | 48.2 | 49 | 49.8 | 50.5 | 51 |
Jun | 47.9 | 48.8 | 49.5 | 50.3 | 50.8 | 51.2 |
Sep | 48 | 48.8 | 49.7 | 50.4 | 50.9 | 51.3 |
Dec | 48.1 | 48.8 | 49.7 | 50.5 | 50.9 | 51.3 |
SEC Filings
Financial Ratios
2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asset Management | ||||||||||||||||||
Inventory / Stock Turnover | 9.8 | 11.1 | 10 | 10.3 | 11.1 | |||||||||||||
Fixed Asset Turnover | 2.1 | 1.4 | 1.3 | 1.4 | 1.4 | |||||||||||||
Total Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | |||||||||||||
Leverage | ||||||||||||||||||
Debt Ratio | 1.9 | 2.1 | 1.6 | 1.8 | 1.8 | |||||||||||||
Debt – Equity Ratio | 0.9 | 1.1 | 0.9 | 1.1 | 1.2 | |||||||||||||
Interest Coverage | 4 | 3 | 6.3 | 3.6 | 3.2 | |||||||||||||
Equity multiplier | 0.7 | 1 | 1 | 1.1 | 1.2 |